ADHD med shortage set to end Supplies of lisdexamfetamine dimesilate should return to normal levels by the end of April, the TGA has advised.
‘I couldn’t walk’: GP’s personal story of vitamin B6 toxicity Found in listed medicines, energy drinks, cereals and weight loss shakes, some people are consuming more than 50x the recommended daily intake.
Can medicine repurposing help GPs? Quality care experts say GPs should consider a new TGA program looking to expand prescribing criteria and medicine access, but there are caveats.
Pharmacy raided in Ozempic crackdown A large quantity of semaglutide was seized from a Melbourne chemist as part of a TGA probe into alleged manufacturing of copycat drugs.
TGA launches medicine shortage investigation GPs are being urged to have their say as part of the inquiry, which aims to ‘better prevent, manage, and communicate shortages’.
Support builds for potential smoking cessation aid With some existing nicotine replacement therapies marked for PBS removal, the RACGP has backed a new scheduling application for cytisine.
TGA moves to address fluoxetine shortage A temporary gap in availability has been addressed by listing an overseas alternative on the PBS.
Live insect find prompts supplement recall Tobacco beetles were found in two batches of dried herb powder promoted as a constipation reliever, the TGA has announced.
RSV vaccine approved by TGA AREXVY will soon be available for patients aged 60 and over, sparking hope it will ease the pressure on Australia’s overflowing hospitals.
GP concern over new Ozempic copycat Telehealth start-up Eucalyptus will soon start selling compounded semaglutide, amid a worldwide shortage of the viral drug.